Targeted Approaches for Treating Advanced Clear Cell Renal Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|29|8-9|394-402

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.8-9, 2006-09, pp. : 394-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy of sunitinib for advanced non‐clear cell renal cell carcinoma

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 328-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 350-354

Karger

Access to resources Recommend Favorite

Targeted mutation analysis of endometrial clear cell carcinoma

By  

HISTOPATHOLOGY, Vol. 66, Iss. 5, 2015-04 ,pp. : 664-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Therapies and Survival: What We Can Learn from Studies in Advanced Renal Cell Carcinoma

By  

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 39-42

Karger

Access to resources Recommend Favorite

Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2988-2995

John Wiley & Sons Inc

Access to resources Recommend Favorite